DeepMed Research

Organogenesis

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: 862

Market Cap: -

Website

Introduction: Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Clinical Trials

Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers

Not Applicable

Completed

Conditions: Diabetic Foot Ulcers

Interventions: Other: Affinity Allograft
Other: Standard of care

First Posted Date: 2016-08-26

Last Posted Date: 2020-02-19

Lead Sponsor: Organogenesis

Target Recruit Count: 89

Registration Number: NCT02880592

Locations: 🇺🇸
Henry Ford Macomb Hospital, Clinton Township, Michigan, United States
🇺🇸
Barry University Clinical Research, North Miami Beach, Florida, United States
🇺🇸
Summit Health Hospital, Chambersburg, Pennsylvania, United States

and more 5 locations

Study of Nucel for One and Two Level Lumbar Interbody Fusion

Not Applicable

Conditions: Spondylolisthesis
Degenerative Disc Disease
Spondylosis

Interventions: Procedure: One or two level lumbar interbody fusion surgery
Other: Nucel

First Posted Date: 2016-06-21

Last Posted Date: 2021-05-26

Lead Sponsor: Organogenesis

Target Recruit Count: 200

Registration Number: NCT02808234

Locations: 🇺🇸
Carolina Neurosurgery & Spine, Charlotte, North Carolina, United States
🇺🇸
Spine Institute of Louisiana, Shreveport, Louisiana, United States
🇺🇸
Florida Orthopaedic Insitute, Tampa, Florida, United States

A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®

Phase 4

Conditions: Venous Leg Ulcers

Interventions: Device: Apligraf

First Posted Date: 2013-12-13

Last Posted Date: 2013-12-13

Lead Sponsor: Organogenesis

Target Recruit Count: 100

Registration Number: NCT02011724

Locations: 🇺🇸
Winthrop University Hospital, Mineola, New York, United States

Safety Study of Gintuit™ in Subjects Requiring Socket Grafting

Phase 1

Terminated

Conditions: Edentulous Alveolar Ridge

Interventions: Biological: Gintuit
Device: Bio-Gide

First Posted Date: 2013-08-28

Last Posted Date: 2015-09-24

Lead Sponsor: Organogenesis

Target Recruit Count: 5

Registration Number: NCT01929954

Locations: 🇺🇸
Kevin G. Murphy and Associates, P.A., Baltimore, Maryland, United States

A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva

Not Applicable

Completed

Conditions: Gingival Recession

Interventions: Device: Gintuit
Other: autologous Free Gingival Graft (FGG)

First Posted Date: 2012-03-08

Last Posted Date: 2012-04-09

Lead Sponsor: Organogenesis

Target Recruit Count: 25

Registration Number: NCT01547962

Locations: 🇺🇸
PerioHealth, Houston, Texas, United States

A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers

Phase 4

Completed

Conditions: Venous Ulcer

Interventions: Device: Apligraf
Other: Standard of Care Dressing Group

First Posted Date: 2011-04-04

Last Posted Date: 2015-09-24

Lead Sponsor: Organogenesis

Target Recruit Count: 30

Registration Number: NCT01327937

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

Not Applicable

Terminated

Conditions: Wounds

Interventions: Device: VCT-01

First Posted Date: 2011-02-09

Last Posted Date: 2012-12-20

Lead Sponsor: Organogenesis

Target Recruit Count: 3

Registration Number: NCT01292122

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers

Phase 3

Completed

Conditions: Diabetic Foot Ulcer

Interventions: Device: Dermagraft
Other: Comparator

First Posted Date: 2010-08-13

Last Posted Date: 2018-05-21

Lead Sponsor: Organogenesis

Target Recruit Count: 314

Registration Number: NCT01181453

Locations: 🇺🇸
University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States

Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers

Phase 3

Completed

Conditions: Diabetic Foot Ulcer

Interventions: Other: Conventional care
Device: Dermagraft(R)

First Posted Date: 2010-08-13

Last Posted Date: 2018-05-21

Lead Sponsor: Organogenesis

Target Recruit Count: 281

Registration Number: NCT01181440

Locations: 🇺🇸
Richard Pollak, DPM, San Antonio, Texas, United States

Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers

Phase 3

Completed

Conditions: Venous Leg Ulcer

Interventions: Device: Dermagraft(R)
Device: Profore

First Posted Date: 2009-05-29

Last Posted Date: 2018-06-18

Lead Sponsor: Organogenesis

Target Recruit Count: 537

Registration Number: NCT00909870

Locations: 🇺🇸
Stony Brook University Medical Center, Stony Brook, New York, United States
🇺🇸
Sutter Roseville Medical Center Wound Care Center, Roseville, California, United States
🇺🇸
VA Northern California Health Care System, Mather, California, United States

and more 67 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy